EDUCATIONAL TOOL ONLY. Not legal or medical advice. Not affiliated with the VA.
← All Condition GuidesCLAIM RECON INTEL
Multiple Sclerosis
DC 8018 | 38 CFR § 4.124a, DC 8018 |
Multiple Sclerosis is rated by the U.S. Department of Veterans Affairs under DC 8018 of 38 CFR § 4.124a, DC 8018 across 3 severity tiers (40%+ -- Severe limitation or ankylosis / 20% -- Moderate limitation / 10% -- Mild limitation or painful motion). Service connection requires (1) a current diagnosis, (2) an in-service event, injury, or exposure, and (3) a medical nexus opinion linking the two under 38 C.F.R. § 3.303. This condition is frequently rated as secondary to Major Depressive Disorder or Fatigue under 38 C.F.R. § 3.310.
OVERVIEW
Chronic autoimmune demyelinating disease of the central nervous system causing variable neurological deficits.
RATING CRITERIA (3 LEVELS)
40%+ -- Severe limitation or ankylosis
Severe limitation of motion or ankylosis of the affected joint. Specific percentages depend on the joint and whether dominant/non-dominant.
20% -- Moderate limitation
Moderate limitation of motion with significant functional impairment. DeLuca factors may increase the effective rating.
10% -- Mild limitation or painful motion
Mild limitation of motion, or X-ray evidence of arthritis with painful motion under DC 5003.
KEY EVIDENCE TO GATHER
-Service treatment records showing injury or complaints
-Imaging (X-ray, MRI, CT)
-Range of motion measurements
-Flare-up documentation per Sharp v. Shulkin
-Buddy statements describing limitations
-Prescription history
-Physical therapy records
-Employment impact documentation
SECONDARY CONDITIONS (12 MAPPED)
DC
MS directly affects brain mood centers; chronic disease burden
DC
Primary MS fatigue from demyelination
DC
White matter lesions affect cognition
DC
Spinal cord lesions affect bladder control
DC
Neurological dysfunction affects bowel
DC
Neurological and psychological factors
DC
Upper motor neuron damage causes spasticity
DC
Neuropathic pain from demyelination
DC
MS commonly affects optic nerve
DC
Demyelination of trigeminal pathway
DC
Immobility and steroids weaken bones
DC
Immobility in advanced MS
C&P EXAM TIPS (6)
1.Do NOT stretch, warm up, or take pain medication before your exam. The VA needs your baseline limitation.
2.Report your WORST day. DeLuca v. Brown requires documentation of functional loss during flare-ups.
3.Tell the examiner about flare-ups: frequency, duration, estimated ROM loss. Sharp v. Shulkin (2017) requires estimates.
4.Request active, passive, weight-bearing, and non-weight-bearing ROM testing per Correia v. McDonald (2016).
5.If you use assistive devices (brace, cane), bring them.
6.Describe daily activity impact: work, sleep, household tasks.
EDUCATIONAL TOOL ONLY. NOT LEGAL OR MEDICAL ADVICE.
NOT AFFILIATED WITH THE U.S. DEPARTMENT OF VETERANS AFFAIRS.
CLAIM RECON 2026